Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

ClinicalTrials.gov ID: NCT02130557

Public ClinicalTrials.gov record NCT02130557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 12:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A MULTICENTER PHASE 3 RANDOMIZED, OPEN-LABEL STUDY OF BOSUTINIB VERSUS IMATINIB IN ADULT PATIENTS WITH NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA

Study identification

NCT ID
NCT02130557
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
536 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 14, 2014
Primary completion
Aug 10, 2016
Completion
Apr 16, 2020
Last update posted
May 17, 2021

2014 – 2020

United States locations

U.S. sites
65
U.S. states
23
U.S. cities
43
Facility City State ZIP Site status
Pacific Cancer Medical Center, Inc. Anaheim California 92801
Emory University Hospital Atlanta Georgia 30322
The Emory Clinic Atlanta Georgia 30322
Winship Cancer Institute, Emory University Atlanta Georgia 30322
Kaiser Permanente Hawaii Honolulu Hawaii 96819
Saint Alphonsus Regional Medical Center, Cancer Care Center Boise Idaho 83706
Saint Alphonsus Regional Medical Center Boise Idaho 83706
Saint Alphonsus Caldwell Cancer Care Center Caldwell Idaho 83605
Saint Alphonsus Medical Center Nampa Nampa Idaho 83686
University of Illinois Cancer Center Chicago Illinois 60612
John H. Stroger, Jr. Hospital of Cook County Chicago Illinois 60621
Indiana Blood and Marrow Transplantation Indianapolis Indiana 46237
PHARMACY Department Franciscan St. Francis Health ATTN:Jill Leslie, Pharm D Indianapolis Indiana 46237
Cancer Center of Acadiana at Lafayette General Medical Center Lafayette Louisiana 70503
Lafayette General Medical Center Lafayette Louisiana 70503
LSU Health Sciences Center-Shreveport Shreveport Louisiana 71103
University Health Shreveport Shreveport Louisiana 71103
Rcca Md Llc Bethesda Maryland 20817
University of Massachusetts Memorial Medical Center, ONC/Research Pharmacy Worcester Massachusetts 01655
University of Massachusetts Memorial Medical Center Worcester Massachusetts 01655
St. Joseph Mercy Hospital - Inpatient Pharmacy Ann Arbor Michigan 48106
St. Joseph Mercy Hospital Ann Arbor Michigan 48106
St. Joseph Mercy-Brighton Brighton Michigan 48114
St. Joseph Mercy-Canton Canton Michigan 48188
Chelsea Community Hospital Chelsea Michigan 48118-1370
St. John Hospital&Medical Center Detroit Michigan 48236
St. John Hospital&Medical Center-Van Elslander Cancer Center Grosse Pointe Woods Michigan 48236
Van Elslander Cancer Center, Pharmacy Grosse Pointe Woods Michigan 48236
Minnesota Oncology Hematology, PA Edina Minnesota 55435
Park Nicollet Frauenshuh Cancer center Saint Louis Park Minnesota 55426
Lakeview Hospital Stillwater Minnesota 55082
North Mississippi Medical Center Hematology and Oncology Clinic Tupelo Mississippi 38801
Nebraska Methodist Hospital Omaha Nebraska 68114
Hackensack University Medical Center Hackensack New Jersey 07601
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601
San Juan Oncology Associates Farmington New Mexico 87401
NYU Winthrop Hospital - Oncology / Hematology department Mineola New York 11501
NYU Winthrop Hospital - Pharmacy Department Mineola New York 11501
Beth Israel Medical Center New York New York 10003
University of Rochester Investigational Drug Pharmacy Rochester New York 14642
University of Rochester Rochester New York 14642
FirstHealth Moore Regional Hospital Pinehurst North Carolina 28374
FirstHealth Outpatient Cancer Center Pinehurst North Carolina 28374
University of Cincinnati Medical Center Cincinnati Ohio 45219
UC Health Physicians Office South, West Chester Ohio 45069
MUSC University Hospital Charleston South Carolina 29425
MUSC University of South Carolina, Investigational Drug Services Charleston South Carolina 29425
MUSC-Hollings Cancer Center Charleston South Carolina 29425
GHS Cancer Institute Easley South Carolina 29640
GHS Cancer Institute Greenville South Carolina 29605
GHS Cancer Institute Greenville South Carolina 29615
GHS Cancer Institute Greer South Carolina 29650
GHS Cancer Institute Seneca South Carolina 29672
GHS Cancer Institute Spartanburg South Carolina 29307
The University of Texas, MD Anderson Cancer Center Houston Texas 77030
Utah Cancer Specialists Murray Utah 84157
Utah Cancer Specialists Salt Lake City Utah 84106
Huntsman Cancer Hospital Salt Lake City Utah 84112
Huntsman Cancer Institute Salt Lake City Utah 84112
Virginia Mason Medical Center Seattle Washington 98101
Seattle Cancer Care Alliance Seattle Washington 98109
HSHS St. Vincent Hospital Regional Cancer Center at HSHS St. Vincent Hospital Green Bay Wisconsin 54301
HSHS St. Vincent Hospital Green Bay Wisconsin 54301
HSHS St. Vincent Hospital Regional Cancer Center at HSHS St. Mary's Hospital Medical Center Green Bay Wisconsin 54303
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 124 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02130557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2021 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02130557 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →